Pennsylvanias premier medical marijuana therapeutics, Ilera Healthcare, company and the main medical cannabis supplier for the entire state, will soon introduce a series of groundbreaking medicines whose formulation is based upon current scientific and clinical research on the effects of cannabis on chronic ailments. Ilera’s latest offering using this technique is HOPE™, which will be available in early May.  Ilera’s research and development team lead by Chief Scientific officer/EVP Dr. Oludare Odumosu.